Compare BWIN & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BWIN | TMDX |
|---|---|---|
| Founded | 2011 | 1998 |
| Country | United States | United States |
| Employees | 5020 | N/A |
| Industry | Specialty Insurers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.5B |
| IPO Year | N/A | 2019 |
| Metric | BWIN | TMDX |
|---|---|---|
| Price | $27.29 | $73.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | $30.43 | ★ $148.22 |
| AVG Volume (30 Days) | ★ 2.1M | 1.1M |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $605,494,000.00 |
| Revenue This Year | $36.36 | $24.25 |
| Revenue Next Year | $10.82 | $18.75 |
| P/E Ratio | ★ N/A | $378.55 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $15.88 | $60.11 |
| 52 Week High | $42.34 | $156.00 |
| Indicator | BWIN | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 61.82 | 50.95 |
| Support Level | $25.80 | $64.87 |
| Resistance Level | $28.59 | $80.72 |
| Average True Range (ATR) | 1.19 | 3.16 |
| MACD | -0.10 | 0.72 |
| Stochastic Oscillator | 63.48 | 65.87 |
The Baldwin Insurance Group Inc is an insurance distribution company operating in the United States. The company provides commercial risk management, employee benefits, private risk management, and personal insurance solutions. It operates through three segments: Insurance Advisory Solutions, which focuses on commercial risk management and employee benefits; Underwriting, Capacity & Technology Solutions, which includes managing general agency operations, reinsurance brokerage, captive management, and technology-enabled insurance products; and Mainstreet Insurance Solutions, which offers personal, commercial, and life and health insurance products through community-based distribution channels.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.